4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-22-007635
Chief Operating Officer sold 22,261 shares at an average $4.36 ($96,986)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bisker-Leib Vered Chief Operating Officer | 2022-11-18 | Sale | −6,226 | $4.40 | $27,394 | 1,107,175 | D |
| Bisker-Leib Vered Chief Operating Officer | 2022-11-21 | Sale | −16,035 | $4.34 | $69,592 | 1,084,914 | D |
| Open-market sales · 22,261 sh · avg $4.36 · $96,986 | |||||||
Loading xslF345X03/ownership.xml…